{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:38:47Z","timestamp":1793831927031,"version":"4.6.1"},"reference-count":207,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>After the 2014, European Society of Cardiology (ESC) guidelines on hypertrophic cardiomyopathy (HCM) were published, the European Association of Cardiovascular Imaging (EACVI) of the ESC developed the 2015 EACVI consensus paper on multi-modality imaging (MMI) in HCM, providing in-depth knowledge on the role of imaging in this disease. Since then, new evidence on HCM diagnosis, management and patient prognosis has accumulated, and the role of MMI has further expanded. Now that the 2023 ESC guidelines on cardiomyopathies have been published, a new EACVI document on MMI in HCM is needed, providing state-of-the-art, in-depth knowledge of imaging in HCM. The scope of this document is to focus on the role of the different imaging techniques in HCM in a logical, didactic and comprehensive way using a multi-modality approach. We provide our vision for future directions on MMI in HCM.<\/jats:p>","DOI":"10.1093\/ehjci\/jeaf282","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:13:52Z","timestamp":1762222432000},"page":"369-399","source":"Crossref","is-referenced-by-count":22,"title":["Role of multi-modality cardiac imaging in the management of patients with hypertrophic cardiomyopathy in 2025. A Clinical Consensus Statement of the European Association of Cardiovascular Imaging (EACVI) of the ESC"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3812-4872","authenticated-orcid":false,"given":"Nuno","family":"Cardim","sequence":"first","affiliation":[{"name":"Hospital CUF Descobertas , Rua M\u00e1rio Botas S\/N 1998-018 Lisbon ,","place":["Portugal"]},{"name":"Nova Medical School, Campo M\u00e1rtires da P\u00e1tria 130, 1169-056 Lisbon ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4900-0453","authenticated-orcid":false,"given":"Kristina","family":"Haugaa","sequence":"additional","affiliation":[{"name":"ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet , Oslo ,","place":["Norway"]},{"name":"University of Oslo , Problemveien 11, 0313 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1031-4084","authenticated-orcid":false,"given":"Saidi A","family":"Mohiddin","sequence":"additional","affiliation":[{"name":"The Cardiovascular Magnetic Resonance Imaging Unit and The Inherited Cardiovascular Diseases Unit, Barts Heart Center St Bartholomew's Hospital , London ,","place":["UK"]},{"name":"Cardiology Department, William Harvey Institute Queen Mary University of London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6377-9566","authenticated-orcid":false,"given":"Rocio","family":"Hinojar","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Hospital Ram\u00f3n y Cajal , Madrid ,","place":["Spain"]},{"name":"Cardiology Department, Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria (IRYCIS) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3315-2006","authenticated-orcid":false,"given":"Alexander","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine and Department of Cardiology, Cardiovascular Institute, Thorax Center, Erasmus MC , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4699-3648","authenticated-orcid":false,"given":"Liliana","family":"Szabo","sequence":"additional","affiliation":[{"name":"Cardiology Department, Semmelweis University Heart and Vascular Centre , Budapest ,","place":["Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6863-9546","authenticated-orcid":false,"given":"Tomaz","family":"Podlesnikar","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, University Medical Centre Maribor , Maribor ,","place":["Slovenia"]},{"name":"Department of Cardiology, University Medical Centre Ljubljana , Ljubljana ,","place":["Slovenia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Dall\u2019Armellina","sequence":"additional","affiliation":[{"name":"Department of Biomedical Imaging Sciences, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds , 8.49J Worsley Building, Clarendon way, Leeds LS2 9JT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3872-8964","authenticated-orcid":false,"given":"Matteo","family":"Cameli","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnologies, Division of Cardiology, University of Siena , Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3184-3006","authenticated-orcid":false,"given":"Giulia Elena","family":"Mandoli","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnologies, Division of Cardiology, University of Siena , Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Aguiar Rosa","sequence":"additional","affiliation":[{"name":"Nova Medical School, Campo M\u00e1rtires da P\u00e1tria 130, 1169-056 Lisbon ,","place":["Portugal"]},{"name":"Department of Cardiology, Hospital de Santa Marta , Lisbon ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Lairez","sequence":"additional","affiliation":[{"name":"Cardiac Imaging Center, Centre Hospitalier Universitaire de Toulouse , Toulouse ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5974-5993","authenticated-orcid":false,"given":"Dimitra","family":"Antonakaki","sequence":"additional","affiliation":[{"name":"Inherited Cardiac Conditions Department, Onassis Hospital, National Transplant Centre , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Maestrini","sequence":"additional","affiliation":[{"name":"Department of Clinical, Internal, Anesthesiological, and Cardiovascular Sciences, Sapienza University of Rome , Rome, Italy"},{"name":"Institute of Sport Medicine and Science, Italian National Olympic Committee , Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9225-5160","authenticated-orcid":false,"given":"Bogdan A","family":"Popescu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Medicine and Pharmacy \u201cCarol Davila\u201d, Euroecolab, Emergency Institute for Cardiovascular Diseases \u201cProf. Dr. C. C. Iliescu\u201d , Sos. Fundeni 258, sector 2, Bucharest 022328 ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9419-8019","authenticated-orcid":false,"given":"Bernard","family":"Cosyns","sequence":"additional","affiliation":[{"name":"Cardiology Department, Centrum voor Hart en Vaatziekten, Universitair Ziekenhuis Brussel, Free University of Brussels , Brussels 1090 ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9083-1582","authenticated-orcid":false,"given":"Erwan","family":"Donal","sequence":"additional","affiliation":[{"name":"Cardiology Department, Universit\u00e9 de Rennes-1 , Rennes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1339-6679","authenticated-orcid":false,"given":"Gianluca","family":"Pontone","sequence":"additional","affiliation":[{"name":"Department of Perioperative Cardiology and Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS , Milan ,","place":["Italy"]},{"name":"Department of Biomedical, Surgical and Dental Sciences, University of Milan , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3800-765X","authenticated-orcid":false,"given":"Thor","family":"Edvardsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Oslo University Hospital, Rikshospitalet , Oslo ,","place":["Norway"]},{"name":"Faculty of Medicine, Institute of Clinical Medicine, University of Oslo , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4622-5160","authenticated-orcid":false,"given":"Steffen E","family":"Petersen","sequence":"additional","affiliation":[{"name":"University of Oslo , Problemveien 11, 0313 Oslo ,","place":["Norway"]},{"name":"William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohann","family":"Bohbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Citro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Debonnaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Dweck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niall","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Giulia","family":"Pavon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valtteri","family":"Uusitalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"2026080909324170100_jeaf282-B1","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"2026080909324170100_jeaf282-B2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/ehjci\/jeu291","article-title":"Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging","volume":"16","author":"Cardim","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCHEARTFAILURE.112.967026","article-title":"Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging","volume":"5","author":"Olivotto","year":"2012","journal-title":"Circ Heart Fail"},{"key":"2026080909324170100_jeaf282-B4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/ehjqcco\/qcaa075","article-title":"Prospective follow-up in various subtypes of cardiomyopathies: insights from the ESC EORP Cardiomyopathy Registry.","volume":"7","author":"Gimeno","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026080909324170100_jeaf282-B5","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the sarcomeric human cardiomyopathy registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"2026080909324170100_jeaf282-B6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCULATIONAHA.115.017633","article-title":"Hypertrophic cardiomyopathy in children, adolescents, and young adults associated with low cardiovascular mortality with contemporary management strategies","volume":"133","author":"Maron","year":"2016","journal-title":"Circulation"},{"key":"2026080909324170100_jeaf282-B7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0002-9149(02)02434-7","article-title":"Correia, usefulness of Doppler myocardial imaging for identification of mutation carriers of familial hypertrophic cardiomyopathy","volume":"90","author":"Cardim","year":"2002","journal-title":"Am J Cardiol"},{"key":"2026080909324170100_jeaf282-B8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamacardio.2016.5670","article-title":"The burden of early phenotypes and the influence of wall thickness in hypertrophic cardiomyopathy mutation carriers: findings from the HCMNet Study","volume":"2","author":"Ho","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2026080909324170100_jeaf282-B9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1148\/radiol.2018180339","article-title":"Left ventricular strain is abnormal in preclinical and overt hypertrophic cardiomyopathy: cardiac MR feature tracking","volume":"290","author":"Vigneault","year":"2019","journal-title":"Radiology"},{"key":"2026080909324170100_jeaf282-B10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/CIRCIMAGING.112.000333","article-title":"T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy","volume":"6","author":"Ho","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B11","doi-asserted-by":"crossref","first-page":"e003285","DOI":"10.1161\/CIRCIMAGING.115.003285","article-title":"T1 mapping in discrimination of hypertrophic phenotypes: hypertensive heart disease and hypertrophic cardiomyopathy: findings from the international T1 multicenter cardiovascular magnetic resonance study","volume":"8","author":"Hinojar","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B12","doi-asserted-by":"crossref","first-page":"e020227","DOI":"10.1161\/JAHA.120.020227","article-title":"Myocardial perfusion defects in hypertrophic cardiomyopathy mutation carriers","volume":"10","author":"Hughes","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026080909324170100_jeaf282-B13","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.jacc.2019.08.1057","article-title":"Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry","volume":"74","author":"Neubauer","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B14","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.jacc.2020.04.045","article-title":"Outcomes in patients with hypertrophic cardiomyopathy and left ventricular systolic dysfunction","volume":"75","author":"Rowin","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","article-title":"Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy","volume":"114","author":"Harris","year":"2006","journal-title":"Circulation"},{"key":"2026080909324170100_jeaf282-B16","doi-asserted-by":"crossref","first-page":"E004200","DOI":"10.1161\/CIRCGEN.123.004200","article-title":"Genotype-phenotype taxonomy of hypertrophic cardiomyopathy","volume":"16","author":"Curran","year":"2023","journal-title":"Circ Genom Precis Med"},{"key":"2026080909324170100_jeaf282-B17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41598-018-19372-4","article-title":"Phenotypic diversity identified by cardiac magnetic resonance in a large hypertrophic cardiomyopathy family with a single MYH7 mutation","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"key":"2026080909324170100_jeaf282-B18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jacc.2024.10.082","article-title":"Demographic-based personalized left ventricular hypertrophy thresholds for hypertrophic cardiomyopathy diagnosis","volume":"85","author":"Shiwani","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00001573-200205000-00006","article-title":"Modifier genes for hypertrophic cardiomyopathy","volume":"17","author":"Marian","year":"2002","journal-title":"Curr Opin Cardiol"},{"key":"2026080909324170100_jeaf282-B20","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jacc.2005.04.043","article-title":"Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy","volume":"46","author":"Olivotto","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B21","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1093\/eurheartj\/ehx639","article-title":"Affairs of the heart: outcomes in men and women with hypertrophic cardiomyopathy","volume":"38","author":"O\u2019Mahony","year":"2017","journal-title":"Eur Heart J"},{"key":"2026080909324170100_jeaf282-B22","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jjcc.2010.07.004","article-title":"Gender-specific differences in the clinical features of hypertrophic cardiomyopathy in a community-based Japanese population: results from Kochi RYOMA study","volume":"56","author":"Kubo","year":"2010","journal-title":"J Cardiol"},{"key":"2026080909324170100_jeaf282-B23","doi-asserted-by":"crossref","first-page":"e102969","DOI":"10.1371\/journal.pone.0102969","article-title":"Female sex is associated with worse prognosis in patients with hypertrophic cardiomyopathy in China","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"2026080909324170100_jeaf282-B24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11897-021-00526-x","article-title":"Sex differences in hypertrophic cardiomyopathy: interaction with genetics and environment","volume":"18","author":"Butters","year":"2021","journal-title":"Curr Heart Fail Rep"},{"key":"2026080909324170100_jeaf282-B25","doi-asserted-by":"crossref","first-page":"E003062","DOI":"10.1161\/CIRCGEN.120.003062","article-title":"Associations between female sex, sarcomere variants, and clinical outcomes in hypertrophic cardiomyopathy","volume":"14","author":"Lakdawala","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"2026080909324170100_jeaf282-B26","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1038\/s41598-021-84335-1","article-title":"Sex differences in the prognosis of patients with hypertrophic cardiomyopathy","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"2026080909324170100_jeaf282-B27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamacardio.2019.4268","article-title":"Association of obesity with adverse long-term outcomes in hypertrophic cardiomyopathy","volume":"5","author":"Fumagalli","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2026080909324170100_jeaf282-B28","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.amjcard.2012.12.018","article-title":"Day, physical activity and other health behaviors in adults with hypertrophic cardiomyopathy","volume":"111","author":"Reineck","year":"2013","journal-title":"Am J Cardiol"},{"key":"2026080909324170100_jeaf282-B29","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1177\/2047487319889714","article-title":"Obesity and metabolic health status are determinants for the clinical expression of hypertrophic cardiomyopathy","volume":"27","author":"Park","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"2026080909324170100_jeaf282-B30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/CIRCULATIONAHA.118.039132","article-title":"Higher body mass index in adolescence predicts cardiomyopathy risk in midlife","volume":"140","author":"Robertson","year":"2019","journal-title":"Circulation"},{"key":"2026080909324170100_jeaf282-B31","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1136\/heartjnl-2021-319861","article-title":"Exercise prescription in individuals with hypertrophic cardiomyopathy: what clinicians need to know","volume":"108","author":"Gati","year":"2022","journal-title":"Heart"},{"key":"2026080909324170100_jeaf282-B32","doi-asserted-by":"crossref","first-page":"e018641","DOI":"10.1161\/JAHA.120.018641","article-title":"Unraveling the genotype-phenotype relationship in hypertrophic cardiomyopathy: obesity-related cardiac defects as a major disease modifier","volume":"9","author":"Nollet","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2026080909324170100_jeaf282-B33","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.amjcard.2013.05.070","article-title":"Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy","volume":"112","author":"Canepa","year":"2013","journal-title":"Am J Cardiol"},{"key":"2026080909324170100_jeaf282-B34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jacc.2013.03.062","article-title":"Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy","volume":"62","author":"Olivotto","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B35","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/jmri.28306","article-title":"Effect of obesity on left ventricular remodeling and clinical outcome in Chinese patients with hypertrophic cardiomyopathy: assessed by cardiac MRI","volume":"57","author":"Shi","year":"2023","journal-title":"J Magn Reson Imaging"},{"key":"2026080909324170100_jeaf282-B36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7861\/clinmed.2023-0194","article-title":"The weight of obesity in hypertrophic cardiomyopathy","volume":"23","author":"Zaromytidou","year":"2023","journal-title":"Clin Med (Lond)"},{"key":"2026080909324170100_jeaf282-B37","doi-asserted-by":"crossref","first-page":"559","DOI":"10.21037\/cdt-19-587","article-title":"Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy","volume":"10","author":"Rayner","year":"2020","journal-title":"Cardiovasc Diagn Ther"},{"key":"2026080909324170100_jeaf282-B38","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00330-016-4468-2","article-title":"Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness \u226515 mm","volume":"27","author":"Rodrigues","year":"2017","journal-title":"Eur Radiol"},{"key":"2026080909324170100_jeaf282-B39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41598-019-57230-z","article-title":"Retrospective analysis of clinical phenotype and prognosis of hypertrophic cardiomyopathy complicated with hypertension","volume":"10","author":"Luo","year":"2020","journal-title":"Sci Rep"},{"key":"2026080909324170100_jeaf282-B40","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s13244-018-0656-8","article-title":"Phenotypes of hypertrophic cardiomyopathy. An illustrative review of MRI findings","volume":"9","author":"Soler","year":"2018","journal-title":"Insights Imaging"},{"key":"2026080909324170100_jeaf282-B41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40292-021-00458-6","article-title":"The many faces of arterial hypertension in hypertrophic cardiomyopathy and its phenocopies: bystander, consequence, modifier","volume":"28","author":"Tini","year":"2021","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"2026080909324170100_jeaf282-B42","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.jcmg.2019.09.020","article-title":"The hypertrophic cardiomyopathy phenotype viewed through the prism of multimodality imaging: clinical and etiologic implications","volume":"13","author":"Rowin","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B43","first-page":"100367","article-title":"Clinical course of adults with co-occurring hypertrophic cardiomyopathy and hypertension: a scoping review","volume":"39","author":"Arabadjian","year":"2024","journal-title":"Am Heart J Plus"},{"key":"2026080909324170100_jeaf282-B44","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/eurheartj\/ehx532","article-title":"European Association of Preventive Cardiology (EAPC) and European Association of Cardiovascular Imaging (EACVI) joint position statement: recommendations for the indication and interpretation of cardiovascular imaging in the evaluation of the athlete's heart","volume":"39","author":"Pelliccia","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080909324170100_jeaf282-B45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.15420\/ecr.2017:12:1","article-title":"Hypertrophic cardiomyopathy in athletes","volume":"12","author":"Malhotra","year":"2017","journal-title":"Eur Cardiol"},{"key":"2026080909324170100_jeaf282-B46","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/bjsm.2008.054726","article-title":"Distinguishing hypertrophic cardiomyopathy from athlete\u2019s heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening","volume":"43","author":"Maron","year":"2009","journal-title":"Br J Sports Med"},{"key":"2026080909324170100_jeaf282-B47","doi-asserted-by":"crossref","first-page":"e0211624","DOI":"10.1371\/journal.pone.0211624","article-title":"The demanding grey zone: sport indices by cardiac magnetic resonance imaging differentiate hypertrophic cardiomyopathy from athlete\u2019s heart","volume":"14","author":"Czimbalmos","year":"2019","journal-title":"PLoS One"},{"key":"2026080909324170100_jeaf282-B48","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3390\/jcdd9100361","article-title":"Certainties and uncertainties of cardiac magnetic resonance imaging in athletes","volume":"9","author":"Szabo","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"2026080909324170100_jeaf282-B49","doi-asserted-by":"crossref","first-page":"e003454","DOI":"10.1161\/CIRCIMAGING.114.003454","article-title":"Clinical profile of athletes with hypertrophic cardiomyopathy","volume":"8","author":"Sheikh","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B50","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijcard.2017.07.015","article-title":"Vigorous exercise in patients with hypertrophic cardiomyopathy","volume":"250","author":"Dejgaard","year":"2018","journal-title":"Int J Cardiol"},{"key":"2026080909324170100_jeaf282-B51","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jcmg.2021.08.012","article-title":"Neither athletic training nor detraining affects LV hypertrophy in adult, low-risk patients with HCM","volume":"15","author":"Pelliccia","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B52","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1136\/bjsports-2019-100890","article-title":"Clinical outcomes in adult athletes with hypertrophic cardiomyopathy: a 7-year follow-up study","volume":"54","author":"Pelliccia","year":"2020","journal-title":"Br J Sports Med"},{"key":"2026080909324170100_jeaf282-B53","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/0002-9149(94)90290-9","article-title":"Surviving competitive athletics with hypertrophic cardiomyopathy","volume":"73","author":"Maron","year":"1994","journal-title":"Am J Cardiol"},{"key":"2026080909324170100_jeaf282-B54","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.jacc.2016.02.054","article-title":"Assessing myocardial extracellular volume by T1 mapping to distinguish hypertrophic cardiomyopathy from athlete's heart","volume":"67","author":"Swoboda","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/eurheartj\/ehaa605","article-title":"ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease","volume":"42","author":"Pelliccia","year":"2021","journal-title":"Eur Heart J"},{"key":"2026080909324170100_jeaf282-B56","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12872-024-03812-3","article-title":"Pregnancy related complications in women with hypertrophic cardiomyopathy: a nationwide population-based cohort study","volume":"24","author":"Choi","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"2026080909324170100_jeaf282-B57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/eurjpc\/zwad257","article-title":"Impact of pregnancy on the natural history of women with hypertrophic cardiomyopathy","volume":"31","author":"Fumagalli","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2026080909324170100_jeaf282-B58","first-page":"143","article-title":"Hypertrophic cardiomyopathy in pregnancy","volume":"39","author":"Saberi","year":"2021","journal-title":"Cardiol Clin"},{"key":"2026080909324170100_jeaf282-B59","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1253\/circj.CJ-14-0541","article-title":"Cardiovascular events in pregnancy with hypertrophic cardiomyopathy","volume":"78","author":"Tanaka","year":"2014","journal-title":"Circulation"},{"key":"2026080909324170100_jeaf282-B60","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1136\/heartjnl-2018-313476","article-title":"Cardiomyopathy and pregnancy","volume":"105","author":"Schaufelberger","year":"2019","journal-title":"Heart"},{"key":"2026080909324170100_jeaf282-B61","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s10554-022-02623-x","article-title":"CMR findings after COVID-19 and after COVID-19-vaccination-same but different?","volume":"38","author":"Doeblin","year":"2022","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B62","doi-asserted-by":"crossref","first-page":"15667","DOI":"10.1038\/s41598-021-95277-z","article-title":"A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients","volume":"11","author":"Drakos","year":"2021","journal-title":"Sci Rep"},{"key":"2026080909324170100_jeaf282-B63","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/jcdd11040104","article-title":"The clinical impact of SARS-CoV-2 on hypertrophic cardiomyopathy","volume":"11","author":"Saleh","year":"2024","journal-title":"J Cardiovasc Dev Dis"},{"key":"2026080909324170100_jeaf282-B64","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/ehf2.13964","article-title":"Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry","volume":"9","author":"Gimeno","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026080909324170100_jeaf282-B65","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.mayocp.2020.04.028","article-title":"Marked up-regulation of ACE2 in hearts of patients with obstructive hypertrophic cardiomyopathy: implications for SARS-CoV-2-mediated COVID-19","volume":"95","author":"Bos","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"2026080909324170100_jeaf282-B66","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jacc.2009.02.075","article-title":"Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy","volume":"54","author":"Bos","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B67","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jacc.2008.08.064","article-title":"Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in differentforms of left ventricular hypertrophy relation to remodeling","volume":"53","author":"Rudolph","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B68","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2012.03.076","article-title":"Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy","volume":"60","author":"Todiere","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B69","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jcmg.2012.09.018","article-title":"Myocardial fibrosis in hypertrophic cardiomyopathy","volume":"6","author":"Moravsky","year":"2013","journal-title":"J Am Coll Cardiol Imaging"},{"key":"2026080909324170100_jeaf282-B70","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jcmg.2023.03.011","article-title":"Subendocardial involvement as an underrecognized LGE subtype related to adverse outcomes in hypertrophic cardiomyopathy","volume":"16","author":"Yang","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B71","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jcmg.2012.10.028","article-title":"Contrast-enhanced CMR in HCM: what lies behind the bright light of LGE and why it now matters","volume":"6","author":"Maron","year":"2013","journal-title":"J Am Coll Cardiol Imaging"},{"key":"2026080909324170100_jeaf282-B72","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1161\/01.CIR.92.9.2488","article-title":"Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990","volume":"92","author":"Cannan","year":"1995","journal-title":"Circulation"},{"key":"2026080909324170100_jeaf282-B73","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.hlc.2008.03.080","article-title":"Myocardial scar detected by contrast-enhanced cardiac magnetic resonance imaging is associated with ventricular tachycardia in hypertrophic cardiomyopathy patients","volume":"17","author":"Suk","year":"2008","journal-title":"Heart Lung Circ"},{"key":"2026080909324170100_jeaf282-B74","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pcad.2020.11.001","article-title":"Risk stratification using late gadolinium enhancement on cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis","volume":"66","author":"Kamp","year":"2021","journal-title":"Prog Cardiovasc Dis"},{"key":"2026080909324170100_jeaf282-B75","first-page":"e558","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"2026080909324170100_jeaf282-B76","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jcmg.2011.06.022","article-title":"Cardiac magnetic resonance in hypertrophic cardiomyopathy","volume":"4","author":"To","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B77","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1148\/radiol.2019190651","article-title":"MRI T1 mapping in hypertrophic cardiomyopathy: evaluation in patients without late gadolinium enhancement and hemodynamic obstruction","volume":"294","author":"Xu","year":"2020","journal-title":"Radiology"},{"key":"2026080909324170100_jeaf282-B78","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.jacc.2004.03.035","article-title":"The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"43","author":"Moon","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B79","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1532-429X-15-92","article-title":"Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement","volume":"15","author":"Moon","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026080909324170100_jeaf282-B80","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026080909324170100_jeaf282-B81","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1136\/heartjnl-2013-304571","article-title":"Linking left ventricular function and mural architecture: what does the clinician need to know?","volume":"100","author":"Partridge","year":"2014","journal-title":"Heart"},{"key":"2026080909324170100_jeaf282-B82","doi-asserted-by":"crossref","first-page":"e15834","DOI":"10.1111\/echo.15834","article-title":"Incremental value of myocardial global longitudinal strain in predicting major adverse cardiac events among patients with hypertrophic cardiomyopathy","volume":"41","author":"Zhuang","year":"2024","journal-title":"Echocardiogr"},{"key":"2026080909324170100_jeaf282-B83","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.amjcard.2017.05.039","article-title":"Role of global longitudinal strain in predicting outcomes in hypertrophic cardiomyopathy","volume":"120","author":"Liu","year":"2017","journal-title":"Am J Cardiol"},{"key":"2026080909324170100_jeaf282-B84","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jcmg.2015.11.001","article-title":"Tissue tracking technology for assessing cardiac mechanics: principles, normal values, and clinical applications","volume":"8","author":"Claus","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B85","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.echo.2020.05.010","article-title":"Myocardial work in nonobstructive hypertrophic cardiomyopathy: implications for outcome","volume":"33","author":"Hiemstra","year":"2020","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080909324170100_jeaf282-B86","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ehjci\/jead236","article-title":"Non-invasive estimation of left ventricular systolic peak pressure: a prerequisite to calculate myocardial work in hypertrophic obstructive cardiomyopathy","volume":"25","author":"Batzner","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B87","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B88","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/ehjci\/jeab154","article-title":"Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging","volume":"23","author":"Smiseth","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B89","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.cpcardiol.2023.102146","article-title":"A systematic review and meta-analysis of left atrial strain in hypertrophic cardiomyopathy and its prognostic utility","volume":"49","author":"Hussain","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"2026080909324170100_jeaf282-B90","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/ehf2.14776","article-title":"Exercise limitation in hypertrophic cardiomyopathy: combined stress echocardiography and cardiopulmonary exercise test","volume":"11","author":"Zamanzadeh","year":"2024","journal-title":"ESC Heart Fail"},{"key":"2026080909324170100_jeaf282-B91","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.amjcard.2024.09.017","article-title":"Diastolic stress echocardiography in patients with hypertrophy cardiomyopathy: association with exercise capacity","volume":"232","author":"Fava","year":"2024","journal-title":"Am J Cardiol"},{"key":"2026080909324170100_jeaf282-B92","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jcmg.2019.02.031","article-title":"CMR in the evaluation of diastolic dysfunction and phenotyping of HFpEF: current role and future perspectives","volume":"13","author":"Chamsi-Pasha","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B93","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0002-9149(81)90605-6","article-title":"Abnormal mitral valve coaptation in hypertrophic obstructive cardiomyopathy: proposed role in systolic anterior motion of mitral valve","volume":"48","author":"Shah","year":"1981","journal-title":"Am J Cardiol"},{"key":"2026080909324170100_jeaf282-B94","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/01.CIR.98.9.856","article-title":"Mechanism of mitral regurgitation in hypertrophic cardiomyopathy: mismatch of posterior to anterior leaflet length and mobility","volume":"98","author":"Schwammenthal","year":"1998","journal-title":"Circulation"},{"key":"2026080909324170100_jeaf282-B95","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.echo.2024.06.011","article-title":"Unmasking obstruction in hypertrophic cardiomyopathy with postprandial resting and treadmill stress echocardiography","volume":"37","author":"Massera","year":"2024","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080909324170100_jeaf282-B96","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.echo.2022.04.010","article-title":"Relation between early diastolic mid-ventricular flow and elastic forces indicating aneurysm formation in hypertrophic cardiomyopathy","volume":"35","author":"Strachinaru","year":"2022","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080909324170100_jeaf282-B97","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.echo.2022.03.012","article-title":"Recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: an update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography","volume":"35","author":"Nagueh","year":"2022","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080909324170100_jeaf282-B98","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12968-020-00623-1","article-title":"Prevalence and clinical significance of cardiovascular magnetic resonance adenosine stress-induced myocardial perfusion defect in hypertrophic cardiomyopathy","volume":"22","author":"Kim","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026080909324170100_jeaf282-B99","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12872-023-03069-2","article-title":"Predictive value of left atrial strain analysis in adverse clinical events in patients with hypertrophic cardiomyopathy: a CMR study","volume":"23","author":"Tian","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"2026080909324170100_jeaf282-B100","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.echo.2015.07.015","article-title":"Right ventricular remodeling, its correlates, and its clinical impact in hypertrophic cardiomyopathy","volume":"28","author":"Ro\u015fca","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080909324170100_jeaf282-B101","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/hupa.2000.16659","article-title":"Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia","volume":"31","author":"Basso","year":"2000","journal-title":"Hum Pathol"},{"key":"2026080909324170100_jeaf282-B102","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0735-1097(86)80181-4","article-title":"Intramural (\u2018small vessel\u2019) coronary artery disease in hypertrophic cardiomyopathy","volume":"8","author":"Maron","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B103","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1253\/circj.66.30","article-title":"Coronary endothelium-dependent and independent vasomotor responses in patients with hypertrophic cardiomyopathy","volume":"66","author":"Yokohama","year":"2002","journal-title":"Circ J"},{"key":"2026080909324170100_jeaf282-B104","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ehjci\/jeab210","article-title":"Phenotyping hypertrophic cardiomyopathy using cardiac diffusion magnetic resonance imaging: the relationship between microvascular dysfunction and microstructural changes","volume":"23","author":"Das","year":"2022","journal-title":"Eur Heart Journal Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B105","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.3390\/jcm11216560","article-title":"Microvascular dysfunction in hypertrophic cardiomyopathy","volume":"11","author":"Pelliccia","year":"2022","journal-title":"J Clin Med"},{"key":"2026080909324170100_jeaf282-B106","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.jacc.2016.07.751","article-title":"Mechanisms of myocardial ischemia in hypertrophic cardiomyopathy: insights from wave intensity analysis and magnetic resonance","volume":"68","author":"Raphael","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B107","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/CIRCULATIONAHA.123.063835","article-title":"Microstructural and microvascular phenotype of sarcomere mutation carriers and overt hypertrophic cardiomyopathy","volume":"148","author":"Joy","year":"2023","journal-title":"Circulation"},{"key":"2026080909324170100_jeaf282-B108","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.echo.2011.03.006","article-title":"American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography","volume":"24","author":"Nagueh","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080909324170100_jeaf282-B109","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.echo.2013.03.023","article-title":"Regional difference of microcirculation in patients with asymmetric hypertrophic cardiomyopathy: transthoracic Doppler coronary flow velocity reserve analysis","volume":"26","author":"Tesic","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080909324170100_jeaf282-B110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijcard.2022.04.032","article-title":"Blunted coronary flow velocity reserve is associated with impairment in systolic function and functional capacity in hypertrophic cardiomyopathy","volume":"359","author":"Aguiar Rosa","year":"2022","journal-title":"Int J Cardiol"},{"key":"2026080909324170100_jeaf282-B111","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.repc.2022.03.003","article-title":"Associations between perfusion defects, tissue changes and myocardial deformation in hypertrophic cardiomyopathy, uncovered by a cardiac magnetic resonancesegmental analysis","volume":"41","author":"Garcia Br\u00e1s","year":"2022","journal-title":"Rev Port Cardiol"},{"key":"2026080909324170100_jeaf282-B112","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/heartjnl-2019-315848","article-title":"Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy","volume":"106","author":"Camaioni","year":"2020","journal-title":"Heart"},{"key":"2026080909324170100_jeaf282-B113","doi-asserted-by":"crossref","first-page":"e014907","DOI":"10.1161\/CIRCIMAGING.122.014907","article-title":"Apical ischemia is a universal feature of apical hypertrophic cardiomyopathy","volume":"16","author":"Hughes","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B114","doi-asserted-by":"crossref","first-page":"e028857","DOI":"10.1161\/JAHA.122.028857","article-title":"Microvascular dysfunction is associated with impaired myocardial work in obstructive and nonobstructive hypertrophic cardiomyopathy: a multimodality study","volume":"12","author":"Garcia Br\u00e1s","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026080909324170100_jeaf282-B115","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jcmg.2022.12.015","article-title":"Myocardial perfusion PET for the detection and reporting of coronary microvascular dysfunction: a JACC Cardiovascular Imaging Expert Panel Statement","volume":"16","author":"Schindler","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B116","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa025050","article-title":"Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy","volume":"349","author":"Cecchi","year":"2003","journal-title":"N Engl J Med"},{"key":"2026080909324170100_jeaf282-B117","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jacc.2005.10.050","article-title":"Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy","volume":"47","author":"Olivotto","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B118","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1172\/JCI116676","article-title":"Bioenergetic abnormalities associated with severe left ventricular hypertrophy","volume":"92","author":"Zhang","year":"1993","journal-title":"J Clin Invest"},{"key":"2026080909324170100_jeaf282-B119","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1161\/01.CIR.97.25.2536","article-title":"31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy","volume":"97","author":"Jung","year":"1998","journal-title":"Circulation"},{"key":"2026080909324170100_jeaf282-B120","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0735-1097(02)03009-7","article-title":"Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy","volume":"41","author":"Crilley","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B121","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ahj.2021.06.010","article-title":"Randomized controlled trial of perhexiline on regression of left ventricular hypertrophy in patients with symptomatic hypertrophic cardiomyopathy (RESOLVE-HCM trial)","volume":"240","author":"Ananthakrishna","year":"2021","journal-title":"Am Heart J"},{"key":"2026080909324170100_jeaf282-B122","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1161\/CIRCULATIONAHA.109.934059","article-title":"Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy","volume":"122","author":"Abozguia","year":"2010","journal-title":"Circulation"},{"key":"2026080909324170100_jeaf282-B123","doi-asserted-by":"crossref","first-page":"101109","DOI":"10.1016\/j.jocmr.2024.101109","article-title":"Cardiac diffusion-weighted and tensor imaging: a consensus statement from the special interest group of the Society for Cardiovascular Magnetic Resonance","volume":"27","author":"Dall'Armellina","year":"2024","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026080909324170100_jeaf282-B124","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jmri.27257","article-title":"Insight into myocardial microstructure of athletes and hypertrophic cardiomyopathy patients using diffusion tensor imaging","volume":"53","author":"Das","year":"2021","journal-title":"J Magn Reson Imaging"},{"key":"2026080909324170100_jeaf282-B125","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.jacc.2019.02.065","article-title":"Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias","volume":"73","author":"Ariga","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B126","doi-asserted-by":"crossref","first-page":"e0188479","DOI":"10.1371\/journal.pone.0188479","article-title":"Evaluation of myocardial glucose metabolism in hypertrophic cardiomyopathy using 18F-fluorodeoxyglucose positron emission tomography","volume":"12","author":"Aoyama","year":"2017","journal-title":"PLoS One"},{"key":"2026080909324170100_jeaf282-B127","first-page":"572","article-title":"Myocardial metabolic changes in hypertrophic cardiomyopathy","volume":"37","author":"Tadamura","year":"1996","journal-title":"J Nucl Med"},{"key":"2026080909324170100_jeaf282-B128","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2214\/ajr.185.2.01850312","article-title":"Comparison of contrast-enhanced MRI with iodine-123 BMIPP for detection of myocardial damage in hypertrophic cardiomyopathy","volume":"185","author":"Amano","year":"2005","journal-title":"AJR Am J Roentgenol"},{"key":"2026080909324170100_jeaf282-B129","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/BF03006666","article-title":"Comparison of myocardial fatty acid metabolism with left ventricular function and perfusion in cardiomyopathies by 123I-BMIPP SPECT and 99mTc-tetrofosmin electrocardiographically gated SPECT","volume":"17","author":"Zhao","year":"2003","journal-title":"Ann Nucl Med"},{"key":"2026080909324170100_jeaf282-B130","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/0735-1097(93)90591-N","article-title":"Diffuse reduction of myocardial beta-adrenoceptors in hypertrophic cardiomyopathy: a study with positron emission tomography","volume":"22","author":"Lefroy","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B131","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.RES.82.1.57","article-title":"Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy","volume":"82","author":"Sch\u00e4fers","year":"1998","journal-title":"Circ Res"},{"key":"2026080909324170100_jeaf282-B132","first-page":"487","article-title":"Cardiac adrenergic activity is associated with left ventricular hypertrophy in genetically homogeneous subjects with hypertrophic cardiomyopathy","volume":"44","author":"Sipola","year":"2003","journal-title":"J Nucl Med"},{"key":"2026080909324170100_jeaf282-B133","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1067\/mnc.2002.122765","article-title":"Impairments of myocardial sympathetic activity may reflect the progression of myocardial damage or dysfunction in hypertrophic cardiomyopathy","volume":"9","author":"Matsuo","year":"2002","journal-title":"J Nucl Cardiol"},{"key":"2026080909324170100_jeaf282-B134","first-page":"909","article-title":"Cardiac 123I-MIBG reflects left ventricular functional reserve in patients with non obstructive hypertrophic cardiomyopathy","volume":"46","author":"Isobe","year":"2005","journal-title":"J Nucl Med"},{"key":"2026080909324170100_jeaf282-B135","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1071-3581(03)00362-3","article-title":"Cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy with malignant ventricular tachyarrhythmias","volume":"10","author":"Terai","year":"2003","journal-title":"J Nucl Cardiol"},{"key":"2026080909324170100_jeaf282-B136","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00259-024-06878-5","article-title":"Enhanced detection of damaged myocardium and risk stratification in hypertrophic cardiomyopathy using integrated [(68)Ga]Ga-FAPI-04 PET\/CMR imaging","volume":"52","author":"Ding","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026080909324170100_jeaf282-B137","doi-asserted-by":"crossref","first-page":"e221052","DOI":"10.1148\/radiol.221052","article-title":"Myocardial activity at (18)F-FAPI PET\/CT and risk for sudden cardiac death in hypertrophic cardiomyopathy","volume":"306","author":"Wang","year":"2023","journal-title":"Radiology"},{"key":"2026080909324170100_jeaf282-B138","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080909324170100_jeaf282-B139","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/ehjci\/jeac099","article-title":"Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance","volume":"23","author":"Huurman","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B140","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCIMAGING.112.972760","article-title":"Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy","volume":"5","author":"Maron","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B141","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/CIRCIMAGING.114.002411","article-title":"Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy","volume":"7","author":"Captur","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B142","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.110.985812","article-title":"Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy","volume":"124","author":"Maron","year":"2011","journal-title":"Circulation"},{"key":"2026080909324170100_jeaf282-B143","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/eurheartj\/ehp121","article-title":"Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death","volume":"30","author":"Basso","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080909324170100_jeaf282-B144","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.amjcard.2018.08.008","article-title":"Multilayer myocardial mechanics in genotype-positive left ventricular hypertrophy-negative patients with hypertrophic cardiomyopathy","volume":"122","author":"Williams","year":"2018","journal-title":"Am J Cardiol"},{"key":"2026080909324170100_jeaf282-B145","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/ehjci\/jeab270","article-title":"EACVI survey on hypertrophic cardiomyopathy","volume":"23","author":"Podlesnikar","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B146","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"2026080909324170100_jeaf282-B147","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jacc.2018.05.060","article-title":"Late gadolinium enhancement in patients with hypertrophic cardiomyopathy and preserved systolic function","volume":"72","author":"Mentias","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B148","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/j.ejrad.2009.05.035","article-title":"Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy","volume":"74","author":"Spiewak","year":"2010","journal-title":"Eur J Radiol"},{"key":"2026080909324170100_jeaf282-B149","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcmg.2023.07.005","article-title":"Quantitative late gadolinium enhancement cardiac magnetic resonance and sudden death in hypertrophic cardiomyopathy: a meta-analysis","volume":"17","author":"Kiaos","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B150","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jcmg.2022.03.029","article-title":"Clinical characteristics and prognostic importance of left ventricular apical aneurysms in hypertrophic cardiomyopathy","volume":"15","author":"Lee","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B151","doi-asserted-by":"crossref","first-page":"e005706","DOI":"10.1161\/CIRCIMAGING.116.005706","article-title":"Global longitudinal strain and left atrial volume index provide incremental prognostic value in patients with hypertrophic cardiomyopathy","volume":"10","author":"Hiemstra","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B152","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.jcmg.2018.07.016","article-title":"Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: a systematic review of existing literature","volume":"12","author":"Tower-Rader","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B153","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/ehjci\/jeab187","article-title":"Supplementary role of left ventricular global longitudinal strain for predicting sudden cardiac death in hypertrophic cardiomyopathy","volume":"23","author":"Lee","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B154","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s10554-021-02165-8","article-title":"Prognostic significance of cardiac magnetic resonance-based markers in patients with hypertrophic cardiomyopathy","volume":"37","author":"Dohy","year":"2021","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B155","doi-asserted-by":"crossref","first-page":"661673","DOI":"10.3389\/fcvm.2021.661673","article-title":"Incremental values of T1 mapping in the prediction of sudden cardiac death risk in hypertrophic cardiomyopathy: a comparison with two guidelines","volume":"8","author":"Qin","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2026080909324170100_jeaf282-B156","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/eurheartj\/ehr092","article-title":"Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy","volume":"32","author":"Christiaans","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080909324170100_jeaf282-B157","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"2026080909324170100_jeaf282-B158","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMoa2401424","article-title":"Aficamten for symptomatic obstructive hypertrophic cardiomyopathy","volume":"390","author":"Maron","year":"2024","journal-title":"N Engl J Med"},{"key":"2026080909324170100_jeaf282-B159","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/CIRCULATIONAHA.120.052359","article-title":"Mavacamten favorably impacts cardiac structure in obstructive hypertrophic cardiomyopathy: EXPLORER-HCM cardiac magnetic resonance substudy analysis","volume":"143","author":"Saberi","year":"2021","journal-title":"Circulation"},{"key":"2026080909324170100_jeaf282-B160","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.jacc.2024.08.015","article-title":"Effect of aficamten on cardiac structure and function in obstructive hypertrophic cardiomyopathy: SEQUOIA-HCM CMR Substudy","volume":"84","author":"Masri","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B161","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2026080909324170100_jeaf282-B162","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"2026080909324170100_jeaf282-B163","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"2026080909324170100_jeaf282-B164","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026080909324170100_jeaf282-B165","doi-asserted-by":"crossref","first-page":"ehaf026","DOI":"10.1093\/eurheartj\/ehaf026","article-title":"Hypertrophic cardiomyopathy: prevalence of disease-specific red flags","volume":"46","author":"Maurizi","year":"2025","journal-title":"Eur Heart J"},{"key":"2026080909324170100_jeaf282-B166","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/ejhf.2997","article-title":"Diagnosis and management of patients with left ventricular hypertrophy: role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology","volume":"25","author":"Moura","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026080909324170100_jeaf282-B167","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.3390\/jcm10153235","article-title":"Dynamic left intraventricular obstruction phenotype in takotsubo syndrome","volume":"10","author":"Di Vece","year":"2021","journal-title":"J Clin Med"},{"key":"2026080909324170100_jeaf282-B168","doi-asserted-by":"crossref","first-page":"e032028","DOI":"10.1161\/JAHA.123.032028","article-title":"Obstructive hypertrophic cardiomyopathy and takotsubo syndrome: how to deal with left ventricular ballooning?","volume":"12","author":"Citro","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026080909324170100_jeaf282-B169","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.echo.2010.07.010","article-title":"Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study","volume":"23","author":"Galderisi","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080909324170100_jeaf282-B170","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCIMAGING.108.838367","article-title":"Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo","volume":"2","author":"Moreo","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B171","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ehjci\/jeae247","article-title":"CMR native T1 and T2 mapping in Olympic athletes: the influence of sports discipline and sex","volume":"26","author":"Prosperi","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B172","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1093\/eurjpc\/zwaa083","article-title":"Hypertrophic cardiomyopathy: insights from extracellular volume mapping","volume":"28","author":"Castelletti","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2026080909324170100_jeaf282-B173","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/ehjci\/jeae021","article-title":"Limitations of apical sparing pattern in cardiac amyloidosis: a multicentre echocardiographic study","volume":"25","author":"Cotella","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B174","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"2026080909324170100_jeaf282-B175","doi-asserted-by":"crossref","first-page":"e009013","DOI":"10.1161\/CIRCIMAGING.119.009013","article-title":"Multimodality imaging assessment of Fabry disease","volume":"12","author":"Tower-Rader","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B176","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.3390\/diagnostics13152598","article-title":"Advanced CMR techniques in Anderson-Fabry disease: state of the art","volume":"13","author":"Ponsiglione","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"2026080909324170100_jeaf282-B177","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2020.12.024","article-title":"Cardiac involvement in Fabry disease: JACC review topic of the week","volume":"77","author":"Pieroni","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B178","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jacc.2023.08.014","article-title":"International consensus on differential diagnosis and management of patients with danon disease: JACC state-of-the-art review","volume":"82","author":"Hong","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B179","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jcmg.2020.08.011","article-title":"Cardiac magnetic resonance imaging in danon disease cardiomyopathy","volume":"14","author":"Rigolli","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B180","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/heartjnl-2014-306387","article-title":"Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy","volume":"101","author":"Lopes","year":"2015","journal-title":"Heart"},{"key":"2026080909324170100_jeaf282-B181","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0025-6196(11)60890-2","article-title":"Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy","volume":"83","author":"Olivotto","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"2026080909324170100_jeaf282-B182","doi-asserted-by":"crossref","first-page":"e005191","DOI":"10.1161\/CIRCHEARTFAILURE.118.005191","article-title":"Incident atrial fibrillation is associated with MYH7 sarcomeric gene variation in hypertrophic cardiomyopathy","volume":"11","author":"Lee","year":"2018","journal-title":"Circ Heart Fail"},{"key":"2026080909324170100_jeaf282-B183","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1136\/heartjnl-2013-303939","article-title":"A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations","volume":"99","author":"Lopes","year":"2013","journal-title":"Heart"},{"key":"2026080909324170100_jeaf282-B184","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0735-1097(01)01386-9","article-title":"Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations","volume":"38","author":"Maron","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B185","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.jacc.2014.09.059","article-title":"Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations","volume":"64","author":"Coppini","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080909324170100_jeaf282-B186","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"key":"2026080909324170100_jeaf282-B187","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/heartjnl-2014-307205","article-title":"Phenotype and prognostic correlations of the converter region mutations affecting the beta myosin heavy chain","volume":"101","author":"Garcia-Giustiniani","year":"2015","journal-title":"Heart"},{"key":"2026080909324170100_jeaf282-B188","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/S2589-7500(20)30267-3","article-title":"Diagnosis and risk stratification in hypertrophic cardiomyopathy using machine learning wall thickness measurement: a comparison with human test-retest performance","volume":"3","author":"Augusto","year":"2021","journal-title":"Lancet Digit Health"},{"key":"2026080909324170100_jeaf282-B189","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1007\/s12410-014-9287-8","article-title":"T1 mapping for characterization of intracellular and extracellular myocardial diseases in heart failure","volume":"7","author":"Maestrini","year":"2014","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"2026080909324170100_jeaf282-B190","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jcct.2023.04.002","article-title":"Identification of subclinical cardiac amyloidosis in aortic stenosis patients undergoing transaortic valve replacement using radiomic analysis of computed tomography myocardial texture","volume":"17","author":"Lo Iacono","year":"2023","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2026080909324170100_jeaf282-B191","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1007\/s10278-024-01013-0","article-title":"A novel data augmentation method for radiomics analysis using image perturbations","volume":"37","author":"Lo Iacono","year":"2024","journal-title":"J Imaging Inform Med"},{"key":"2026080909324170100_jeaf282-B192","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jcct.2019.04.007","article-title":"Advanced atherosclerosis imaging by CT: radiomics, machine learning and deep learning","volume":"13","author":"Kolossvary","year":"2019","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2026080909324170100_jeaf282-B193","doi-asserted-by":"crossref","first-page":"e221693","DOI":"10.1148\/radiol.221693","article-title":"A coronary CT angiography radiomics model to identify vulnerable plaque and predict cardiovascular events","volume":"307","author":"Chen","year":"2023","journal-title":"Radiology"},{"key":"2026080909324170100_jeaf282-B194","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcmg.2023.05.003","article-title":"Radiomics of late gadolinium enhancement reveals prognostic value of myocardial scar heterogeneity in hypertrophic cardiomyopathy","volume":"17","author":"Fahmy","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B195","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12968-022-00869-x","article-title":"Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy","volume":"24","author":"Fahmy","year":"2022","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026080909324170100_jeaf282-B196","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/CIRCULATIONAHA.121.054432","article-title":"Toward replacing late gadolinium enhancement with artificial intelligence virtual native enhancement for gadolinium-free cardiovascular magnetic resonance tissue characterization in hypertrophic cardiomyopathy","volume":"144","author":"Zhang","year":"2021","journal-title":"Circulation"},{"key":"2026080909324170100_jeaf282-B197","doi-asserted-by":"crossref","first-page":"586236","DOI":"10.3389\/fcvm.2020.586236","article-title":"Repeatability of cardiac magnetic resonance radiomics: a multi-centre multi-vendor test-retest study","volume":"7","author":"Raisi-Estabragh","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"2026080909324170100_jeaf282-B198","doi-asserted-by":"crossref","first-page":"H610","DOI":"10.1152\/ajpheart.2001.280.2.H610","article-title":"Regional nonuniformity of normal adult human left ventricle","volume":"280","author":"Bogaert","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026080909324170100_jeaf282-B199","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.amjcard.2010.01.020","article-title":"Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathy","volume":"105","author":"Fattori","year":"2010","journal-title":"Am J Cardiol"},{"key":"2026080909324170100_jeaf282-B200","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/hrt.2003.014969","article-title":"Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography","volume":"90","author":"Moon","year":"2004","journal-title":"Heart"},{"key":"2026080909324170100_jeaf282-B201","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijcard.2015.01.054","article-title":"Diagnosis of apical hypertrophic cardiomyopathy: T-wave inversion and relative but not absolute apical left ventricular hypertrophy","volume":"183","author":"Flett","year":"2015","journal-title":"Int J Cardiol"},{"key":"2026080909324170100_jeaf282-B202","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ehjci\/jew045","article-title":"CMR assessment of the left ventricle apical morphology in subjects with unexplainable giant T-wave inversion and without apical wall thickness \u226515 mm","volume":"18","author":"Wu","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B203","first-page":"501","article-title":"Improved diagnostic criteria for apical hypertrophic cardiomyopathy","volume":"17","author":"Hughes","year":"2024","journal-title":"J Am Coll Cardiol Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B204","first-page":"513","article-title":"Personalizing apical hypertrophic cardiomyopathy diagnosis: a major step forward, but challenges remain","volume":"17","author":"Raman","year":"2024","journal-title":"J Am Coll Cardiol Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B205","first-page":"1135","article-title":"Myocardial stiffness evaluation using noninvasive shear wave imaging in healthy and hypertrophic cardiomyopathic adults","volume":"12","author":"Villemain","year":"2019","journal-title":"J Am Coll Cardiol Cardiovasc Imaging"},{"key":"2026080909324170100_jeaf282-B206","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population","volume":"186","author":"Fry","year":"2017","journal-title":"Am J Epidemiol"},{"key":"2026080909324170100_jeaf282-B207","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/jamacardio.2021.0689","article-title":"Prevalence of hypertrophic cardiomyopathy in the UK Biobank population","volume":"6","author":"Lopes","year":"2021","journal-title":"JAMA Cardiol"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeaf282\/65133114\/jeaf282.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/27\/3\/369\/65133114\/jeaf282.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/27\/3\/369\/65133114\/jeaf282.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T13:34:32Z","timestamp":1786282472000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/27\/3\/369\/8313597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":207,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,11,4]]},"published-print":{"date-parts":[[2026,2,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jeaf282","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,11,4]]}}}